Oligonucleotide ALS therapy approved in EU
The European Commission (EC) has granted Biogen its third rare…
The European Commission (EC) has granted Biogen its third rare disease treatment approval in the European Union.
List view / Grid view
The European Commission (EC) has granted Biogen its third rare…
The European Commission (EC) has granted Biogen its third rare disease treatment approval in the European Union.